COVID vaccines
Japan's 1st plant for mRNA COVID vaccine to be built by Daiichi Sankyo
Drugmaker targets capacity of 20m doses yearly, boosting nation's preparedness
Pandemic is likely at a 'transition point,' World Health Organization says
Overloaded hospitals and morgues suggest true death toll is hidden and worst is to come
Global immunization high enough, so no restrictions needed: health minister
Following the shots, adults had 27 times higher levels of virus-neutralizing antibodies
Shionogi and KM Biologics also eye homegrown shots targeting variants
Sudden policy changes, spread of virus cast shadow over 'V-shaped recovery'
Mainlanders flock to enclave, prepare for Hong Kong border to reopen to get shots
Medics needed; drugstores told to limit ibuprofen sales to 6 pills per person per week
Company aims for 73m doses by fiscal 2027 to become dominant producer
Logistics equipment to help boost vaccine shipments to islands
Government's pandemic preparation plan depends on commitments from drugmakers
Jakarta now has homegrown halal alternative to Western, Chinese shots
Chancellor, on Beijing trip, wants vaccine available to all Chinese citizens
No-needle products win approval in India and beyond
CanSino, Sinopharm seek Chinese equivalents of Pfizer and Moderna shots
Southeast Asian country aims to be more self-sufficient in dealing with pandemic
As 20th Party Congress approaches, China appears trapped by draconian anti-virus policies
Injections due to start this month with 43m doses to be supplied nationwide
Materials maker to invest in Yokohama plant, preparing for pandemics
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.